Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Qiuxiao Shi"'
Autor:
Zhao Li, Tianshan She, Hao Yang, Tao Su, Qiuxiao Shi, Ze Tao, Yanru Feng, Fen Yang, Jingqiu Cheng, Xiaofeng Lu
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 1698-1711 (2022)
Multidrug resistance (MDR), which is common in colorectal cancer (CRC), induces high mortality in patients. Due to its robust and selective apoptosis induction in some CRC cells with MDR, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL
Externí odkaz:
https://doaj.org/article/913375aacb15471187edafb8ccd1c214
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1818-1830 (2017)
Vascular-targeted photodynamic therapy (PDT) is an important strategy for cancer therapy. Conventional vascular-targeted PDT has been achieved by passive photosensitizer (PS) delivery, which involves a high risk of adverse effects. Active PS delivery
Externí odkaz:
https://doaj.org/article/e554ddb99aff4a93ba64c7163279f10e
Autor:
Huawei Cai, Zhao Li, Qiuxiao Shi, Hao Yang, Liu Xiao, Mufeng Li, Hua Lin, Xiaoai Wu, Tianshan She, Lihong Chen, Lin Li, Xiaofeng Lu
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging.
Abstract Purpose Hepatocellular carcinoma (HCC) is a highly vascularized solid carcinoma and tumor vessel–targeted molecular imaging might be effective for early diagnosis of HCC. Herein, we developed a novel trimeric affibody (ZTRI) with highly sp
Autor:
Xiaofeng Lu, Qiuxiao Shi, Youmei Jin, Zhao Li, Jingqiu Cheng, Yanru Feng, Hao Yang, Tianshan She, Heng Li, Jie Chen, Ze Tao, Jie Fan
Publikováno v:
Journal of Controlled Release. 340:243-258
Immunotherapies based on immune checkpoint-blocking antibodies have been considered the most attractive cancer treatments in recent years. However, the systemic administration of immune checkpoint-blocking antibodies is limited by low response rates
Autor:
Hao Yang, Heng Li, Fen Yang, Ze Tao, Qiuxiao Shi, Tianshan She, Yanru Feng, Zhao Li, Jie Chen, Yi Zhong, Tao Su, Wengjuan Zeng, Yong Zhang, Shisheng Wang, Lan Li, Tingting Long, Dan Long, Jingqiu Cheng, Hong Zhu, Xiaofeng Lu
Publikováno v:
Biomaterials. 295:121994
Autor:
Hao Yang, Xiaofeng Lu, Ze Tao, Jie Fan, Zhao Li, Shengfu Li, Youmei Jin, Qiuxiao Shi, Yanru Feng, Jie Chen, Jingqiu Cheng
Publikováno v:
Applied Microbiology and Biotechnology
Due to their potent immune stimulation, tumor necrosis factor alpha (TNFα) variants with tumor-homing activity are attractive as novel antitumor drugs. The promising antitumor effect of NGR-TNFα in clinical trials triggered extensive interest in de
Autor:
Ze Tao, Tianshan She, Yanru Feng, Shisheng Wang, Heng Li, Xiaofeng Lu, Yan Liang, Zhao Li, Jingqiu Cheng, Hao Yang, Jie Chen, Qiuxiao Shi
Publikováno v:
Theranostics
Chemotherapeutic multidrug resistance (MDR) is the major hindrance for clinical therapy of colorectal cancer (CRC). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with selective cytotoxicity might overcome MDR of CRC cells. Unfortuna
Publikováno v:
Apoptosis. 25:105-119
Liver fibrosis usually progresses to liver cirrhosis and even hepatocellular carcinoma. Since activated hepatic stellate cells (aHSCs) are responsible for liver fibrosis, reducing the quantity of aHSCs was considered the essential strategy for clinic
Autor:
Ze Tao, Hao Yang, Qiuxia Huang, Shan Liu, Lan Li, Yanru Feng, Liqiang Hu, Hong Tan, Qiuxiao Shi, Tao Su, Shengfu Li, Yi Zhong
Publikováno v:
International Journal of Nanomedicine
Yi Zhong,1,* Tao Su,1,* Qiuxiao Shi,1 Yanru Feng,1 Ze Tao,1 Qiuxia Huang,1 Lan Li,1 Liqiang Hu,1 Shengfu Li,1 Hong Tan,2 Shan Liu,3 Hao Yang1 1Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Re
Autor:
Fang Xie, Ze Tao, Xiaofeng Lu, Rong Tian, Xiaoai Wu, Hao Yang, Qiuxiao Shi, Haoxing Wu, Yue Chen, Yu Tang, Huawei Cai, Nan Liu, Yuanyou Yang, Lin Li, Lihong Chen
Publikováno v:
Molecular Pharmaceutics. 16:1950-1957
Platelet-derived growth factor receptor β (PDGFRβ) is overexpressed in a variety of malignant cancers, plays a critical role in tumor angiogenesis, and has been proven as a valuable target for cancer treatment. In this pilot study, a dimeric affibo